National Health Investors Inc
NYSE:NHI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
National Health Investors Inc
NYSE:NHI
|
US |
Balance Sheet
Balance Sheet Decomposition
National Health Investors Inc
National Health Investors Inc
Balance Sheet
National Health Investors Inc
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
43
|
94
|
161
|
133
|
159
|
75
|
100
|
46
|
3
|
16
|
9
|
11
|
3
|
13
|
5
|
3
|
5
|
5
|
43
|
37
|
19
|
22
|
24
|
20
|
|
| Cash Equivalents |
43
|
94
|
161
|
133
|
159
|
75
|
100
|
46
|
3
|
16
|
9
|
11
|
3
|
13
|
5
|
3
|
5
|
5
|
43
|
37
|
19
|
22
|
24
|
20
|
|
| Total Receivables |
7
|
4
|
6
|
6
|
9
|
2
|
2
|
2
|
5
|
9
|
12
|
21
|
39
|
63
|
82
|
103
|
112
|
89
|
98
|
99
|
81
|
90
|
94
|
85
|
|
| Accounts Receivables |
7
|
4
|
6
|
6
|
9
|
2
|
2
|
0
|
1
|
0
|
0
|
3
|
4
|
3
|
9
|
5
|
6
|
3
|
3
|
3
|
4
|
5
|
6
|
7
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
0
|
0
|
19
|
35
|
60
|
73
|
97
|
106
|
86
|
96
|
96
|
77
|
85
|
87
|
79
|
|
| Total Current Assets |
50
|
98
|
168
|
138
|
168
|
77
|
102
|
48
|
8
|
25
|
22
|
33
|
42
|
76
|
86
|
106
|
117
|
95
|
142
|
137
|
100
|
112
|
118
|
105
|
|
| PP&E Net |
304
|
290
|
278
|
263
|
235
|
188
|
181
|
224
|
328
|
395
|
535
|
1 248
|
1 777
|
1 837
|
2 160
|
2 286
|
2 367
|
2 560
|
2 667
|
2 318
|
2 118
|
2 107
|
2 211
|
2 474
|
|
| PP&E Gross |
304
|
290
|
278
|
263
|
235
|
188
|
181
|
224
|
328
|
395
|
535
|
1 248
|
1 777
|
1 837
|
2 160
|
2 286
|
2 367
|
2 560
|
2 667
|
2 318
|
2 118
|
2 107
|
2 211
|
2 474
|
|
| Accumulated Depreciation |
99
|
111
|
124
|
132
|
141
|
122
|
130
|
127
|
136
|
147
|
163
|
174
|
212
|
259
|
313
|
380
|
452
|
515
|
598
|
577
|
612
|
673
|
742
|
822
|
|
| Note Receivable |
201
|
150
|
112
|
119
|
100
|
142
|
109
|
95
|
76
|
79
|
84
|
61
|
64
|
134
|
134
|
142
|
246
|
340
|
292
|
300
|
233
|
245
|
269
|
203
|
|
| Long-Term Investments |
59
|
71
|
74
|
68
|
96
|
94
|
65
|
60
|
61
|
52
|
63
|
60
|
63
|
80
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
37
|
29
|
2
|
47
|
26
|
6
|
4
|
5
|
5
|
29
|
3
|
69
|
46
|
7
|
2
|
4
|
|
| Other Assets |
36
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
12
|
0
|
8
|
8
|
16
|
18
|
16
|
16
|
11
|
17
|
14
|
11
|
|
| Total Assets |
651
N/A
|
624
-4%
|
631
+1%
|
588
-7%
|
598
+2%
|
501
-16%
|
457
-9%
|
459
+1%
|
509
+11%
|
580
+14%
|
706
+22%
|
1 456
+106%
|
1 983
+36%
|
2 133
+8%
|
2 404
+13%
|
2 546
+6%
|
2 751
+8%
|
3 042
+11%
|
3 121
+3%
|
2 839
-9%
|
2 507
-12%
|
2 488
-1%
|
2 614
+5%
|
2 797
+7%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
29
|
31
|
28
|
27
|
24
|
7
|
4
|
3
|
3
|
4
|
4
|
8
|
16
|
19
|
20
|
18
|
20
|
26
|
25
|
23
|
26
|
33
|
36
|
44
|
|
| Accrued Liabilities |
5
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
9
|
13
|
16
|
13
|
26
|
38
|
19
|
18
|
17
|
24
|
25
|
47
|
51
|
54
|
57
|
61
|
53
|
58
|
61
|
50
|
39
|
39
|
41
|
44
|
|
| Total Current Liabilities |
42
|
48
|
47
|
42
|
53
|
45
|
23
|
21
|
20
|
28
|
29
|
55
|
66
|
73
|
77
|
78
|
73
|
84
|
86
|
73
|
65
|
73
|
79
|
88
|
|
| Long-Term Debt |
203
|
164
|
156
|
118
|
114
|
10
|
4
|
0
|
38
|
97
|
203
|
617
|
863
|
914
|
1 116
|
1 146
|
1 282
|
1 441
|
1 499
|
1 243
|
1 148
|
1 135
|
1 146
|
1 164
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
11
|
10
|
9
|
0
|
0
|
0
|
1
|
11
|
10
|
20
|
20
|
19
|
18
|
|
| Other Liabilities |
5
|
4
|
3
|
3
|
0
|
0
|
0
|
4
|
9
|
11
|
6
|
7
|
4
|
3
|
1
|
0
|
6
|
20
|
13
|
6
|
5
|
6
|
4
|
5
|
|
| Total Liabilities |
251
N/A
|
215
-14%
|
206
-4%
|
163
-21%
|
167
+2%
|
55
-67%
|
28
-50%
|
25
-10%
|
67
+170%
|
136
+104%
|
249
+83%
|
689
+177%
|
943
+37%
|
1 000
+6%
|
1 194
+19%
|
1 224
+2%
|
1 361
+11%
|
1 545
+13%
|
1 608
+4%
|
1 332
-17%
|
1 237
-7%
|
1 235
0%
|
1 248
+1%
|
1 275
+2%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
19
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
58
|
61
|
56
|
52
|
48
|
31
|
40
|
40
|
36
|
30
|
19
|
3
|
1
|
20
|
30
|
33
|
18
|
5
|
22
|
85
|
330
|
350
|
371
|
402
|
|
| Additional Paid In Capital |
440
|
441
|
461
|
464
|
462
|
462
|
459
|
460
|
462
|
466
|
468
|
754
|
1 034
|
1 085
|
1 174
|
1 290
|
1 370
|
1 506
|
1 541
|
1 591
|
1 599
|
1 604
|
1 737
|
1 923
|
|
| Other Equity |
1
|
11
|
20
|
12
|
18
|
14
|
11
|
14
|
15
|
7
|
8
|
10
|
6
|
28
|
6
|
1
|
1
|
3
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
400
N/A
|
410
+2%
|
426
+4%
|
425
0%
|
432
+2%
|
446
+3%
|
430
-4%
|
435
+1%
|
443
+2%
|
444
+0%
|
457
+3%
|
767
+68%
|
1 040
+36%
|
1 133
+9%
|
1 210
+7%
|
1 322
+9%
|
1 390
+5%
|
1 498
+8%
|
1 512
+1%
|
1 507
0%
|
1 270
-16%
|
1 254
-1%
|
1 366
+9%
|
1 522
+11%
|
|
| Total Liabilities & Equity |
651
N/A
|
624
-4%
|
631
+1%
|
588
-7%
|
598
+2%
|
501
-16%
|
457
-9%
|
459
+1%
|
509
+11%
|
580
+14%
|
706
+22%
|
1 456
+106%
|
1 983
+36%
|
2 133
+8%
|
2 404
+13%
|
2 546
+6%
|
2 751
+8%
|
3 042
+11%
|
3 121
+3%
|
2 839
-9%
|
2 507
-12%
|
2 488
-1%
|
2 614
+5%
|
2 797
+7%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
27
|
27
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
33
|
38
|
38
|
40
|
42
|
43
|
45
|
45
|
46
|
43
|
43
|
46
|
48
|
|
| Preferred Shares Outstanding |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|